Literature DB >> 22181692

Synthesis and in vitro antifungal evaluation of 1,3,5-trisubstituted-2-pyrazoline derivatives.

Hui Deng1, Zhi-Yi Yu, Guan-Ying Shi, Ming-Jing Chen, Ke Tao, Tai-Ping Hou.   

Abstract

Pyrazolines, the well-known five-membered nitrogen-containing heterocyclic compounds, have received considerable interests in the fields of medicinal and agricultural chemistry because of their broad spectrum of biological activities. To discover more potent antifungal compounds, a series of structurally related 1,3,5-trisubstituted-2-pyrazoline derivatives have been synthesized by introducing furan rings regarded as bioactive substructure into the scaffold of pyrazolines and tested for their activities against six plant pathogenic fungi in vitro. The preliminary bioassays indicated that almost all synthesized compounds had displayed variable growth inhibitory effects on the tested pathogenic fungi. In particular, compounds 4, 7, 9, 12, 18, 19, and 38 displayed excellent antifungal activities against Rhizoctonia solani and their inhibition of growth reached 100% at the concentration of 20 mg/L. Additionally, compounds 9 and 19 bearing two furan rings, respectively, at site 3 and site 5 of the pyrazoline cycle showed the strongest activities against R. solani (the EC(50) were 3.46 mg/L and 3.20 mg/L). The bioactivity results provide good starting templates for further structural optimization of pyrazoline derivatives.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22181692     DOI: 10.1111/j.1747-0285.2011.01308.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  5 in total

1.  Crystal structures of (5RS)-(Z)-4-[5-(furan-2-yl)-3-phenyl-4,5-di-hydro-1H-pyrazol-1-yl]-4-oxobut-2-enoic acid and (5RS)-(Z)-4-[5-(furan-2-yl)-3-(thio-phen-2-yl)-4,5-di-hydro-1H-pyrazol-1-yl]-4-oxobut-2-enoic acid.

Authors:  Kseniya K Borisova; Flavien A A Toze; Nniyaz Z Yagafarov; Fedor I Zubkov; Pavel V Dorovatovskii; Yan V Zubavichus; Victor N Khrustalev
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-10-11

2.  Microwave-assisted synthesis and bioevaluation of new sulfonamides.

Authors:  Halise Inci Gul; Cem Yamali; Fatma Yesilyurt; Hiroshi Sakagami; Kaan Kucukoglu; Ilhami Gulcin; Mustafa Gul; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides.

Authors:  Halise Inci Gul; Ebru Mete; Sakip Emre Eren; Hiroshi Sakagami; Cem Yamali; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-23       Impact factor: 5.051

4.  4-(2H-1,3-Benzodioxol-5-yl)-1-(4-methyl-phenyl)-1H-pyrazol-5-amine.

Authors:  Nilesh N Gajera; Mukesh C Patel; Mukesh M Jotani; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-17

5.  A monoclinic polymorph of 4-(2H-1,3-benzodioxol-5-yl)-1-(4-methyl-phen-yl)-1H-pyrazol-5-amine.

Authors:  Mukesh M Jotani; Nilesh N Gajera; Mukesh C Patel; Herman H Y Sung; Edward R T Tiekink
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.